ARTG 460504VersaCross Access Solution - Transseptal access system
ARTG ID: 460504 · Boston Scientific Pty Ltd · Baylis Medical Company Inc · Class III · Started August 23, 2024
Good Name: Boston Scientific Pty Ltd - VersaCross Access Solution - Transseptal access system
- Risk Class
- Class III
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 460504
- Start Date
- August 23, 2024
- Effective Date
- August 23, 2024
- Country
- Canada
- Address
- 5959 Trans-Canada Highway, Montreal, Quebec, H4T 1A1
The VersaCross Access Solution is indicated for creation of an atrial septal defect in the heart and for the percutaneous introduction of various types of cardiovascular catheters and guidewires to all heart chambers, including the left atrium via transseptal perforation/puncture.
Access comprehensive regulatory information for VersaCross Access Solution - Transseptal access system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 460504 and sponsored by Boston Scientific Pty Ltd, manufactured by Baylis Medical Company Inc in Canada. The device registration started on August 23, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.